Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03896074
Title Atezolizumab Versus Atezolizumab Plus Bevacizumab as First Line in NSCLC Patients (BEAT) (BEAT)
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Fondazione Ricerca Traslazionale

lung non-squamous non-small cell carcinoma


Atezolizumab + Bevacizumab


Age Groups: senior | adult
Covered Countries ITA

Facility Status City State Zip Country Details
AOU Ospedali Riuniti "Umberto I- G.M.Lancisi-G.Salesi" Ancona 60020 Italy Details
IRCCS Oncologico Istituto Tumori "Giovanni Paolo II" Bari 70124 Italy Details
P.O. Antonio Perrino Brindisi 72100 Italy Details
A.O. Per l' emergenza Cannizzaro Catania 95126 Italy Details
Irccs S.R.L. Irst Meldola 47014 Italy Details
AO Papardo Messina 98158 Italy Details
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milano 20122 Italy Details
Istituto Nazionale Tumori di Napoli IRCCS Pascale Napoli 80131 Italy Details
Ospedale Sacro Cuore- Don Calabria Negrar 37024 Italy Details
AOU S. Luigi Orbassano Orbassano 10043 Italy Details
IRCCS ISTITUTO Oncologico Veneto Padova 35128 Italy Details
Arcispedale Santa Maria Nuova Reggio Emilia 42100 Italy Details
Azienda Ospedaliera San Camillo-Forlanini Roma 00152 Italy Details
IRCCS Ospedale Casa Sollievo della Sofferenza San Giovanni Rotondo 71013 Italy Details
ASST Sette Laghi Varese 21100 Italy Details
AUOI di Verona- Borgo Trento Verona 37126 Italy Details
*Shaded cells indicate that there was no data available from for the field